Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colvin R. B., Fuller T. C., MacKeen L., Kung P. C., Ip S. H., Cosimi A. B. Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol. 1987 May;43(2):273–276. doi: 10.1016/0090-1229(87)90135-8. [DOI] [PubMed] [Google Scholar]
- Kloster B. E., John P. A., Miller L. E., Rubin L. A., Nelson D. L., Blair D. C., Tomar R. H. Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clin Immunol Immunopathol. 1987 Dec;45(3):440–446. doi: 10.1016/0090-1229(87)90095-x. [DOI] [PubMed] [Google Scholar]
- Malkovský M., Sondel P. M., Strober W., Dalgleish A. G. The interleukins in acquired disease. Clin Exp Immunol. 1988 Nov;74(2):151–161. [PMC free article] [PubMed] [Google Scholar]
- O'Garra A. Interleukins and the immune system 1. Lancet. 1989 Apr 29;1(8644):943–947. [PubMed] [Google Scholar]
- Oliver R. T. The clinical potential of interleukin-2. Br J Cancer. 1988 Oct;58(4):405–409. doi: 10.1038/bjc.1988.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pizzolo G., Chilosi M., Semenzato G. The soluble interleukin-2 receptor in haematological disorders. Br J Haematol. 1987 Dec;67(4):377–380. doi: 10.1111/j.1365-2141.1987.tb06156.x. [DOI] [PubMed] [Google Scholar]
- Pizzolo G., Chilosi M., Vinante F., Dazzi F., Lestani M., Perona G., Benedetti F., Todeschini G., Vincenzi C., Trentin L. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br J Cancer. 1987 Apr;55(4):427–428. doi: 10.1038/bjc.1987.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg S. A., Lotze M. T., Muul L. M., Chang A. E., Avis F. P., Leitman S., Linehan W. M., Robertson C. N., Lee R. E., Rubin J. T. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med. 1987 Apr 9;316(15):889–897. doi: 10.1056/NEJM198704093161501. [DOI] [PubMed] [Google Scholar]
- Rovelli F., Lissoni P., Crispino S., Barni S., Fumagalli G., Paolorossi F., Tancini G. Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary study. Tumori. 1988 Dec 31;74(6):633–637. doi: 10.1177/030089168807400603. [DOI] [PubMed] [Google Scholar]
- Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981 Apr;126(4):1393–1397. [PubMed] [Google Scholar]
- Wang H. M., Smith K. A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med. 1987 Oct 1;166(4):1055–1069. doi: 10.1084/jem.166.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- West W. H., Tauer K. W., Yannelli J. R., Marshall G. D., Orr D. W., Thurman G. B., Oldham R. K. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med. 1987 Apr 9;316(15):898–905. doi: 10.1056/NEJM198704093161502. [DOI] [PubMed] [Google Scholar]